Skip to main content

Advertisement

Log in

Von Hippel-Lindau disease type 2 in a Chinese family with a VHL p.W88X truncation

Endocrine Aims and scope Submit manuscript

Abstract

Von Hippel-Lindau (VHL) disease is an autosomal dominant syndrome caused by germline mutations in the synonymous VHL gene encoding a tumor suppressor. Affected individuals are susceptible to various benign and malignant tumors. Based on the phenotypes, VHL disease is classified as type 1 and type 2. Here, we describe a Chinese family diagnosed as VHL disease type 2, with different metabolic status of tumors on FDG PET-CT. Genetic analysis revealed a germline c.264G > A point mutation, resulting in premature termination at codon 88 (p.W88X). This pedigree represents a rare link between p.W88X nonsense mutation (genotype) and VHL disease type 2 (phenotype), which has not been previously described. This is also the first nonsense mutation to manifest as VHL disease type 2 in ethnic Chinese. We also reviewed the literature and provided an outline of mutations associated with VHL disease in China.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

References

  1. F. Latif, K. Tory, J. Gnarra, M. Yao, F.M. Duh, M.L. Orcutt, T. Stackhouse, I. Kuzmin, W. Modi, L. Geil et al., Identification of the von Hippel-Lindau disease tumor suppressor gene. Science 260, 1317–1320 (1993)

    Article  CAS  PubMed  Google Scholar 

  2. R.R. Lonser, G.M. Glenn, M. Walther, E.Y. Chew, S.K. Libutti, W.M. LinehanE, H. Oldfield, Von Hippel-Lindau disease. Lancet 361, 2059–2067 (2003)

    Article  CAS  PubMed  Google Scholar 

  3. T. Mete, D. Berker, E. Yilmaz, G. Ozgen, Y. Yalcin, M. Tuna, D. Ciliz, M. Onen, Y. AydinS, S. Guler, Clinical presentation of von Hippel Lindau syndrome type 2B associated with VHL p. A149S mutation in a large Turkish family. Endocrine 45, 128–135 (2014)

    Article  CAS  PubMed  Google Scholar 

  4. B. Zbar, T. Kishida, F. Chen, L. Schmidt, E.R. Maher, F.M. Richards, P.A. Crossey, A.R. Webster, N.A. Affara, M.A. Ferguson-Smith, H. Brauch, D. Glavac, H.P. Neumann, S. Tisherman, J.J. Mulvihill, D.J. Gross, T. Shuin, J. Whaley, B. Seizinger, N. Kley, S. Olschwang, C. Boisson, S. Richard, C.H. Lips, M. Lerman et al., Germline mutations in the von Hippel-Lindau disease (VHL) gene in families from North America, Europe, and Japan. Hum. Mutat. 8, 348–357 (1996)

    Article  CAS  PubMed  Google Scholar 

  5. A. Porollo, J. Meller, Versatile annotation and publication quality visualization of protein complexes using POLYVIEW-3D. BMC Bioinform. 8, 316 (2007)

    Article  Google Scholar 

  6. H. Li, B. Handsaker, A. Wysoker, T. Fennell, J. Ruan, N. Homer, G. Marth, G. Abecasis, R. DurbinS, Genome project DATA Processing, the sequence alignment/map format and samtools. Bioinform. 25, 2078–2079 (2009)

    Article  Google Scholar 

  7. R. Li, Y. Li, X. Fang, H. Yang, J. Wang, K. Kristiansen, J. Wang, SNP detection for massively parallel whole-genome resequencing. Genome Res. 19, 1124–1132 (2009)

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  8. D.E. Kang, R.L. White Jr, J.H. Zuger, H.C. SasserC, M. Teigland, Clinical use of fluorodeoxyglucose F 18 positron emission tomography for detection of renal cell carcinoma. J. Urol. 171, 1806–1809 (2004)

    Article  PubMed  Google Scholar 

  9. S. Solav, R. Bhandari, Fluorodeoxyglucose positron emission tomography-computed tomography scan in von Hippel-Lindau syndrome: a case report and review of literature. Indian J. Nucl. Med. 27, 119–121 (2012)

    Article  PubMed Central  PubMed  Google Scholar 

  10. J. Zhang, Y. Huang, J. Pan, D. Liu, L. Zhou, W. Xue, Q. Chen, B. Dong, H. Xuan, Germline mutations in the von Hippel-Lindau disease (VHL) gene in mainland Chinese families. J. Cancer Res. Clin. Oncol. 134, 1211–1218 (2008)

    Article  CAS  PubMed  Google Scholar 

  11. W.K. Siu, R.C. Ma, C.W. Lam, C.M. Mak, Y.P. Yuen, F.M. Lo, K.W. Chan, S.F. Lam, S.C. Ling, S.F. Tong, W.Y. So, C.C. Chow, M.H. Tang, W.H. TamA, Y. Chan, Molecular basis of von Hippel-Lindau syndrome in Chinese patients. Chin. Med. J. (Engl) 124, 237–241 (2011)

    CAS  Google Scholar 

  12. Y. Huang, D. Zhou, J. Liu, P. Zhou, X. LiZ, Z. Wang, Germline mutations of the VHL gene in seven Chinese families with von Hippel-Lindau disease. Int. J. Mol. Med. 29, 47–52 (2012)

    PubMed  Google Scholar 

  13. P. Wu, N. Zhang, X. Wang, X. Ning, T. Li, D. BuK, K. Gong, Family history of von Hippel-Lindau disease was uncommon in Chinese patients: suggesting the higher frequency of de novo mutations in VHL gene in these patients. J. Hum. Genet. 57, 238–243 (2012)

    Article  CAS  PubMed  Google Scholar 

  14. J. Chen, W. Geng, Y. Zhao, H. Zhao, G. Wang, F. Huang, F. LiuX, X. Geng, Clinical and mutation analysis of four Chinese families with von Hippel-Lindau disease. Clin. Transl. Oncol. 15, 391–397 (2013)

    Article  CAS  PubMed  Google Scholar 

  15. Y. Gao, Y.P. Huang, X.A. Tu, D.S. Luo, D.H. Wang, S.P. Qiu, P. Xiang, W.Q. Li, R. Jan, Y.Y. Zhang, X.Z. SunC, H. Deng, Genetic characterization and protein stability analysis of a Chinese family with von Hippel-Lindau disease. Chin Med J (Engl) 126, 3690–3693 (2013)

    Google Scholar 

  16. D. Jia, B. Tang, Y. Shi, J. Wang, Z. Sun, Z. Chen, L. Zhang, K. Xia, H. Jiang, A deletion mutation of the VHL gene associated with a patient with sporadic von Hippel-Lindau disease. J Clin Neurosci 20, 842–847 (2013)

    Article  CAS  PubMed  Google Scholar 

  17. Y. Lu, J. Lu, Q. Liu, J. Niu, S.M. Zhang, Q.Y. Wu, X.F. Qi, A c.464T > a mutation in VHL gene in a Chinese family with VHL syndrome. J. Neurooncol. 111, 313–318 (2013)

    Article  CAS  PubMed  Google Scholar 

  18. X.P. Qi, W.T. Liu, J.Y. Li, Y. Dai, J.M. Ma, Y. Zhao, J. Fei, F. Li, M. Shen, H.Y. Jin, Z.G. Chen, Z.F. Du, X.L. Chen, X.N. Zhang, p.N78S and p.R161Q germline mutations of the VHL gene are present in von Hippel-Lindau syndrome in two pedigrees. Mol. Med. Rep. 8, 799–805 (2013)

    CAS  PubMed  Google Scholar 

  19. Y. Su, W.D. Shen, C.C. Wang, W.J. Han, J. Liu, Z.H. Hou, Z.G. Song, D.L. Huang, D.Y. HanS, M. Yang, Endolymphatic sac tumor with von Hippel-Lindau disease: report of two cases with testing of von Hippel-Lindau gene. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 48, 913–918 (2013)

    PubMed  Google Scholar 

  20. X. Ding, C. Zhang, J. M. Frerich, A. Germanwala, C. Yang, R. R. Lonser, Y. Mao, Z. Zhuang, M. Zhang, De novo VHL germline mutation detected in a patient with mild clinical phenotype of von Hippel-Lindau disease. J Neurosurg, (2014)

  21. M. Ohh, C.W. Park, M. Ivan, M.A. Hoffman, T.Y. Kim, L.E. Huang, N. Pavletich, V. ChauW, G. Kaelin, Ubiquitination of hypoxia-inducible factor requires direct binding to the beta-domain of the von Hippel-Lindau protein. Nat. Cell. Biol. 2, 423–427 (2000)

    Article  CAS  PubMed  Google Scholar 

  22. J.H. Min, H. Yang, M. Ivan, F. Gertler, W.G. Kaelin Jr, N.P. Pavletich, Structure of an HIF-1alpha -pVHL complex: hydroxyproline recognition in signaling. Science 296, 1886–1889 (2002)

    Article  CAS  PubMed  Google Scholar 

  23. F. Chen, T. Kishida, M. Yao, T. Hustad, D. Glavac, M. Dean, J.R. Gnarra, M.L. Orcutt, F.M. Duh, G. Glenn et al., Germline mutations in the von Hippel-Lindau disease tumor suppressor gene: correlations with phenotype. Hum. Mutat. 5, 66–75 (1995)

    Article  CAS  PubMed  Google Scholar 

  24. S. Olschwang, S. Richard, C. Boisson, S. Giraud, P. Laurent-Puig, F. Resche, G. Thomas, Germline mutation profile of the VHL gene in von Hippel-Lindau disease and in sporadic hemangioblastoma. Hum. Mutat. 12, 424–430 (1998)

    Article  CAS  PubMed  Google Scholar 

  25. C. Gallou, D. Joly, A. Mejean, F. Staroz, N. Martin, G. Tarlet, M.T. Orfanelli, R. Bouvier, D. Droz, Y. Chretien, J.M. Marechal, S. Richard, C. Junien, C. Beroud, Mutations of the VHL gene in sporadic renal cell carcinoma: definition of a risk factor for VHL patients to develop an RCC. Hum. Mutat. 13, 464–475 (1999)

    Article  CAS  PubMed  Google Scholar 

  26. S. Glasker, B.U. Bender, T.W. Apel, E. Natt, V. van Velthoven, R. Scheremet, J. ZentnerH, P. Neumann, The impact of molecular genetic analysis of the VHL gene in patients with haemangioblastomas of the central nervous system. J. Neurol. Neurosurg. Psychiatry 67, 758–762 (1999)

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  27. C. Mattocks, P. Tarpey, M. BobrowJ, J. Whittaker, Comparative sequence analysis (CSA): a new sequence-based method for the identification and characterization of mutations in DNA. Hum. Mutat. 16, 437–443 (2000)

    Article  CAS  PubMed  Google Scholar 

  28. J.C. Rocha, R.L. Silva, B.B. Mendonca, S. Marui, A.J. Simpson, A.A. Camargo, High frequency of novel germline mutations in the VHL gene in the heterogeneous population of Brazil. J. Med. Genet. 40, e31 (2003)

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  29. J.M. Whaley, J. Naglich, L. Gelbert, Y.E. Hsia, J.M. Lamiell, J.S. Green, D. Collins, H.P. Neumann, J. Laidlaw, F.P. Li et al., Germ-line mutations in the von Hippel-Lindau tumor-suppressor gene are similar to somatic von Hippel-Lindau aberrations in sporadic renal cell carcinoma. Am. J. Hum. Genet. 55, 1092–1102 (1994)

    PubMed Central  CAS  PubMed  Google Scholar 

  30. G. Eisenhofer, H.J. Timmers, J.W. Lenders, S.R. Bornstein, O. Tiebel, M. Mannelli, K.S. King, C.D. Vocke, W.M. Linehan, G. Bratslavsky, K. Pacak, Age at diagnosis of pheochromocytoma differs according to catecholamine phenotype and tumor location. J. Clin. Endocrinol. Metab. 96, 375–384 (2011)

    Article  PubMed Central  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This work was supported by the National Natural Science Foundation of China (Grant number: 81100557) and the Specialized Research Fund for the Doctoral Program of Higher Education (Grant number: 20110073120086). We are grateful to all members of the family who participated in this study.

Conflict of interest

Nothing to declare.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jingjing Jiang.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (TIFF 3749 kb)

Supplementary material 2 (DOCX 30 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhang, M., Wang, J., Jiang, J. et al. Von Hippel-Lindau disease type 2 in a Chinese family with a VHL p.W88X truncation. Endocrine 48, 83–88 (2015). https://doi.org/10.1007/s12020-014-0368-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12020-014-0368-x

Keywords

Navigation